The more the better? Quadruplets in newly diagnosed multiple myeloma

Dr Ola Carl Landgren from Sylvester Comprehensive Cancer Center (FL, USA) recently presented at the 2024 ASCO Annual Meeting (May 31–June 4, IL, USA) about the potential of quadruplet therapies in newly diagnosed multiple myeloma. In this interview, he provides a breakdown of key takeaways from his talk and discusses challenges and opportunities in this area. What were the key takeaways from the discussion on quadruplet therapy approaches in multiple myeloma presented at this years ASCO? By adding a fourth drug to an existing backbone with three drugs, it provides a higher degree of efficacy (more MRD negativity and longer...